Alyeska Investment Group, L.P. Repligen Corp Transaction History

Alyeska Investment Group, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$138.42 - $180.31 $21.3 Million - $27.7 Million	-153,519 Reduced 38.57%	244,484 $34.6 Million
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $61.4 Million - $78.8 Million	398,003 New	398,003 $67 Million
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $17.1 Million - $22.9 Million	121,786 Added 622.28%	141,357 $23 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $3.15 Million - $5.05 Million	19,571 New	19,571 $3.68 Million

479

54.5M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.22B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.